Kakolie Banerjee

Placeholder Person Graphic
Scientist III in Virology and Microbiological Sciences
Kakolie G. Banerjee, PhD, is a Scientist III in virology and microbiological sciences at MilliporeSigma. She is a virologist in the process solutions business, supporting bioprocessing efforts. Her work includes viral inactivation and clearance studies using model mammalian viruses and bacteriophage. Prior to that, Kakolie worked as a Staff Scientist at Sample6 (now Corvium, Inc.) and helped develop an AOAC-certified high-throughput phage-based method to detect foodborne pathogens. She received her BS in life science from the University of Dehli, India, a MS in food safety from North Dakota State University, and a PhD in food science from Pennsylvania State University.

Related Articles

Figure 1: Batch manufacturing process vs. a low pH iVI process.
Technical
Continuous Process: Implementing Low pH Viral Inactivation in a Continuous Process

Viral inactivation (VI) is a critical step in ensuring the safety of monoclonal antibody (mAb), Fc fusion, and recombinant protein therapeutics and it is typically an important component of an overall virus control strategy for downstream biotherapeutic production processes. Considerations for successful implementation of an inline VI process are discussed in this article.